PubRank

Benjamin W Van Tassell

Author PubWeight™ 29.33‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study). Am J Cardiol 2010 1.82
2 The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse. Proc Natl Acad Sci U S A 2011 1.81
3 Cirrhotic cardiomyopathy. J Am Coll Cardiol 2010 1.77
4 Medication nonadherence: an unrecognized cardiovascular risk factor. MedGenMed 2007 1.73
5 Controversy and conflict in the treatment of acute decompensated heart failure: nesiritide as evidence-based treatment. Pharmacotherapy 2007 1.38
6 Alpha-1 antitrypsin inhibits caspase-1 and protects from acute myocardial ischemia-reperfusion injury. J Mol Cell Cardiol 2011 1.23
7 Interleukin-1beta modulation using a genetically engineered antibody prevents adverse cardiac remodelling following acute myocardial infarction in the mouse. Eur J Heart Fail 2010 1.19
8 Right ventricular dysfunction following acute myocardial infarction in the absence of pulmonary hypertension in the mouse. PLoS One 2011 1.06
9 Interleukin-18 mediates interleukin-1-induced cardiac dysfunction. Am J Physiol Heart Circ Physiol 2014 1.00
10 Silencing of hypoxia-inducible factor-1α gene attenuated angiotensin II-induced renal injury in Sprague-Dawley rats. Hypertension 2011 0.96
11 Blocking interleukin-1 as a novel therapeutic strategy for secondary prevention of cardiovascular events. BioDrugs 2012 0.92
12 Alterations in the interleukin-1/interleukin-1 receptor antagonist balance modulate cardiac remodeling following myocardial infarction in the mouse. PLoS One 2011 0.91
13 GS-6201, a selective blocker of the A2B adenosine receptor, attenuates cardiac remodeling after acute myocardial infarction in the mouse. J Pharmacol Exp Ther 2012 0.90
14 Comparative cardiac toxicity of anthracyclines in vitro and in vivo in the mouse. PLoS One 2013 0.86
15 Pharmacologic inhibition of phosphoinositide 3-kinase gamma (PI3Kγ) promotes infarct resorption and prevents adverse cardiac remodeling after myocardial infarction in mice. J Cardiovasc Pharmacol 2010 0.85
16 Interleukin-1β blockade improves cardiac remodelling after myocardial infarction without interrupting the inflammasome in the mouse. Exp Physiol 2012 0.85
17 A mouse model of radiation-induced cardiomyopathy. Int J Cardiol 2012 0.85
18 Recombinant human interleukin-1 receptor antagonist provides cardioprotection during myocardial ischemia reperfusion in the mouse. Cardiovasc Drugs Ther 2012 0.84
19 Pharmacologic Inhibition of the NLRP3 Inflammasome Preserves Cardiac Function After Ischemic and Nonischemic Injury in the Mouse. J Cardiovasc Pharmacol 2015 0.84
20 Inhibition of apoptosis signal-regulating kinase 1 reduces myocardial ischemia-reperfusion injury in the mouse. J Am Heart Assoc 2012 0.84
21 Parecoxib inhibits apoptosis in acute myocardial infarction due to permanent coronary ligation but not due to ischemia-reperfusion. J Cardiovasc Pharmacol 2009 0.82
22 Altered oxido-reductive state in the diabetic heart: loss of cardioprotection due to protein disulfide isomerase. Mol Med 2011 0.81
23 Right ventricular systolic dysfunction in patients with reperfused ST-segment elevation acute myocardial infarction. Int J Cardiol 2011 0.80
24 Interleukin-1β blockade improves left ventricular systolic/diastolic function and restores contractility reserve in severe ischemic cardiomyopathy in the mouse. J Cardiovasc Pharmacol 2014 0.79
25 Obesity Contributes to Exercise Intolerance in Heart Failure With Preserved Ejection Fraction. J Am Coll Cardiol 2016 0.78
26 Cellular preservation therapy in acute myocardial infarction. Am J Physiol Heart Circ Physiol 2009 0.78
27 Intracellular function of interleukin-1 receptor antagonist in ischemic cardiomyocytes. PLoS One 2013 0.76
28 Limited value of brain natriuretic peptide as a prognostic marker in acute heart failure--a meta-analysis. Int J Cardiol 2010 0.75
29 Effects of PI3Kgamma inhibition using AS-605240 in acute myocardial infarction. Circ Res 2010 0.75
30 Recombinant Human Alpha-1 Antitrypsin-Fc Fusion Protein Reduces Mouse Myocardial Inflammatory Injury After Ischemia-Reperfusion Independent of Elastase Inhibition. J Cardiovasc Pharmacol 2016 0.75
31 Levosimendan in advanced heart failure: where do we stand? J Cardiovasc Pharmacol 2017 0.75